DLL3’s distinctive expression pattern - markedly elevated in SCLC tissues but virtually absent in normal tissues - suggests a pivotal role in the neuroendocrine characteristics that define SCLC (42)(Figure 2). Here, DLL3 is linked to small cell lung carcinoma.